Exclusive Speaker Interview with Myeloid Therapeutics
In this interview, Daniel Getts, CEO of Myeloid Therapeutics, shares his opinion on the latest in vivo technology advancements, biggest challenges the industry faces and his predictions for the next in vivo breakthrough!
"At the end of the day, we're all in this together, working toward the same goal: transforming patient lives through ground-breaking science."
Daniel Getts, Chief Executive Officer
